Significant sale by President of R&D Fouad Namouni implies s...
Significant sale by President of R&D Fouad Namouni implies shares may not be undervalued. This, along with multiple insider sales, is a potential red flag for investors.
Blueprint Medicines Insiders Sold US$2.1m Of Shares Suggesting Hesitancy
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment